Pharmafile Logo

Advancing digital engagement in pharma and healthcare: 2024 focus areas

6 areas for pharma and healthcare organisations to focus efforts in 2024 to drive better digital engagement amongst patients, HCPs and other users

We’ve spent the past 12 months creating digital products and services for our clients, attending and speaking at industry events, and having conversations with leaders across the sector about their digital challenges and priorities.

Based on these combined insights, we share our top focus areas for organisations looking to advance their digital engagement in 2024.

1. Practical omnichannel

Most organisations have an omnichannel strategy and enabling technology in place by now.

The conversation has moved on from being something all organisations need to do, to something that everyone is now doing in some capacity — with varying degrees of success.

In 2024 we expect to see better results, with customer segments identified, pathways and funnels defined, and content and channels aligned to meet their audiences. We look forward to seeing brands succeeding and sharing their wins with the industry.

The best commercial results will be observed with those brands that have adopted behaviour-change models like AIDA, as mentioned by Andrew Binns in our recent webinar.

Taking an iterative approach to omnichannel strategies will also improve the chances of success — learn as you go, experiment, analyse the data, seek customer insight, then scale the approaches that work.

2. Content is king (still)

Valuable content sits at the centre of marketing.

It’s crucial to create content that genuinely adds value and is sympathetic to the needs and contexts of audiences. This is the only way to cut through the noise and drive audience engagement.

Organisations can build trust by providing transparent, educational and authentic content across a variety of formats and channels to suit individual needs and preferences.

We hope to see an even higher level of value-add in medical comms and a higher degree of creativity in brand campaigns and activation over the next 12 months.

3. Data is essential

Despite nearly every organisations saying they need to be more data-driven, it feels like progress in this area has been slow and the conversation hasn’t moved on much in the past 12 months.

Leaders want to see data and tangible ROI from digital marketing activity, and bringing that data into the business is more important than ever in 2024.

Determining the right metrics to track will be key to using data successfully. What is being measured has a direct impact on behaviour and internal culture, because that’s how teams are being incentivised. If organisations want to be customer-centric, they need to prioritise the data points that facilitate this.

4. Focus on User Experience

With effective journey orchestration becoming a priority, focus should be placed on the touchpoints that customers engage with — yes, all of them.

Content and user experience need to work together. There’s no point investing in creating great content if your customers can’t conveniently access it. Teams should focus on improving the impact, look and feel of their digital products through human-centric design. Simplify user journeys to help users quickly locate the information they need and complete their intended tasks.

Recognise that customers will be engaging with multiple channels and touchpoints that each need to be highly usable, accessible and connected.

We can help with usability, accessibility and effectiveness audits. Get in touch to learn more.

5. Scaling successful solutions

Pharma and healthcare organisations are looking hard at the platforms that power their digital engagement strategies. Getting them right is key for efficiency and scaling.

Many organisations are now embracing design systems to allow them to scale their platforms across brands, devices and markets without losing consistency and quality. Tasks that are often considered time-consuming, like the migration of multiple unique sites to a new visual identity or UX, can be hugely accelerated.

Whether it’s your design tools, CMS platform, CRM or analytics dashboard, investing in the right tools in the right combination will be key for future-proofing your digital products and strategies so that they can grow with you.

A switch to a new digital platform can seem like a daunting task, but it will pay off in the long run and can be painless if you work with an experienced partner. Having clear and comprehensive documentation will empower marketers and AORs to embrace new platforms and use them effectively, along with thought-out internal launch, training and socialisation plans.

6. More use cases for AI

In an article looking at 2024 digital focus areas, we couldn’t avoid mentioning AI…

It feels like the hype around AI might have reached a peak in 2023. Our hope for 2024 is that we see use cases that demonstrate it’s not something to be feared and can help create better experiences for customers.

One way that AI could be transformational in terms of digital engagement is by utilising it to process the vast amount of data that pharma organisations hold. Those that can harness the power of AI to generate sophisticated customer insight on a vast scale, then apply this across their omnichannel strategies, will get ahead of the competition.

A word of warning — unless tools are used intelligently, and staff upskilled to use them properly, they’ll end up as expensive licence fees with zero ROI.

New to Graphite?

We’re a digital customer experience agency collaborating with clients in the healthcare and pharmaceutical sectors to create more meaningful and effective digital experiences using UX research, strategy, and design.

If you’re looking for a partner to support you with elevating your digital services in 2024 and beyond, get in touch.

This content was provided by Graphite Digital

Company Details

 Latest Content from  Graphite Digital 

Pharma’s digital dilemma: Finding the balance between speed, scale, and experience

What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der Heiden (AstraZeneca) argued it starts with design systems. This quick...

Redefining digital ROI: Engagement, experience, and the new metrics of success

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and...

5 key digital CX challenges in pharma, and how to start solving them

Creating great digital experiences in pharma isn’t easy, but progress doesn’t always need to come from big projects or budgets. Here are 5 common challenges that leading digital teams are...

Driving behaviour change for positive patient outcomes in pharma

Discover how pharma can help to achieve better patient health outcomes by informing patient behaviour through insights, strategy and collaboration.

How Design Systems enable streamlined regulatory approval in digital pharma

The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...

Disconnected pharma: Navigating digital challenges and priorities in 2024

We are delighted to present Graphite’s research whitepaper for 2024 — and this year we are able to share the challenges and priorities that digital leaders are finding, in this...

How to successfully manage change and enable digital transformation within pharma

Change is an essential aspect of any business, and learning to manage it effectively will be key for long-term success. Getting your team on board with change and digital transformation...

How Design Systems enable streamlined regulatory approval in digital pharma

The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...

Ensuring a seamless transition from design to development: Strategies for successful collaboration

When designing digital products and services, the process of transitioning from design to development plays a critical role in bringing concepts to life. Our Design Lead, Edward Hart, explains why...

Is your pharma brand site meeting HCP expectations? Our checklist of common mistakes

Here’s 8 things you can check your brand site for today to ensure it’s delivering, and engaging HCPs.